Association of poorly controlled HbA1c with increased risk of progression to end-stage kidney disease and all-cause mortality in patients with diabetes and chronic kidney disease

Association of poorly controlled HbA1c with increased risk of progression to end-stage kidney disease and all-cause mortality in patients with diabetes and chronic kidney disease

Show other versions (1)

Glycosylated hemoglobin (HbA1c) targets for patients with chronic kidney disease (CKD) and type 2 diabetes remain controversial. To evaluate whether baseline HbA1c and HbA1c trajectories are associated with the risk of end-stage kidney disease (ESKD) and all-cause mortality, we recruited adult patie...

Full description

Bibliographic Details
Main Authors: Sheng-Jen Chen, Hsiu-Yin Chiang, Pei-Shan Chen, Shih-Ni Chang, Sheng-Hsuan Chen, Min-Yen Wu, Hung-Chieh Yeh, I-Wen Ting, Hsiu-Chen Tsai, Pei-Chun Chen, Chin-Chi Kuo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512200/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512200/?tool=EBI

Similar Items